Community Concerns Regarding the Google-Autism Speaks Ten Thousand Genomes Program (AUT10K)
By admin,
ASAN
| 06. 12. 2014
In response to the recent announcement of the new Google-Autism Speaks collaboration to produce, expand and analyze the world’s largest private collection of DNA samples of autistic children and adults, many in the autistic community have expressed significant concerns regarding the initiative. The program, entitled the Autism Speaks Ten Thousand Genomes Program (AUT10K), will utilize genetic material collected from autistic children and adults as part of the Autism Genetic Resource Exchange (AGRE) for academic and commercial research purposes. A number of critical questions and concerns have emerged regarding the program:
- Autism Speaks Lacks Representation from the Community it Purports to Serve: Autism Speaks is a particularly concerning partner for such an initiative. The organization has long been subject to criticism for its lack of any representation of autistic people on its board of directors or in its senior leadership. Autism Speaks’ research budget has largely ignored research inquiries focused on improving the lives of autistic people alive today, with only 1% of its research budget going towards services issues and 0.25% going towards research on the needs of adults. Furthermore...
Related Articles
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Kiana Jackson and Shannon Stubblefield, New Disabled South | 02.09.2026
"MC0_8230" via Wikimedia Commons licensed under CC by 2.0
This report documents a deliberate assault on disabled people in the United States. Not an accident. Not a series of bureaucratic missteps. An assault that has been coordinated across agencies...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...